M. B. B. McCall

A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial

G. van Gemert, M. M. Jore, R. Sauerwein, 2024, BMC medicine.

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

H. Wertheim, J. Bukh, S. Justesen, 2023, The Lancet Microbe.

Different Patterns of Toll-Like Receptor 2 Polymorphisms in Populations of Various Ethnic and Geographic Origins

M. Oosting, L. Joosten, M. Netea, 2012, Infection and Immunity.